Some individuals may experience mild side effects such as redness or soreness at the injection site
Why this matters: Daily oral semaglutide offers an alternative to weekly injections Lower cash prices compared to injectables: $149$299/month Available at 70,000+ pharmacies (CVS, Costco) and telehealth platforms like Ro, LifeMD, Weight Watchers, GoodRx, and NovoCare Approved not only for weight loss, but also for reducing cardiovascular risk in adults with obesity Clinical impact: Phase 3 trials showed up to 16.6% average weight loss at 64 weeks Same active ingredient as injectable Wegovy, targeting appetite via GLP-1 pathways Industry perspective: With the global GLP-1 market projected to approach $100B by the 2030s, oral therapies may capture nearly 24% of the market, reshaping access, adherence, and affordability
Its unique mechanism of action provides additional metabolic benefits, such as improved glucose control and appetite suppression, making it appealing for both weight loss and diabetes management
Going back to relative valuation and the relative extremes in the market, its mind boggling
Due to the increased content of trace elements daily ration should not be more than doubled
The development program runs from Phase 1b through three completed Phase 3 readouts, with several more ongoing